| Literature DB >> 23997796 |
Jun-Ichi Yamakawa1, Yoshiharu Motoo, Junji Moriya, Masao Ogawa, Hiroaki Uenishi, Sumiyo Akazawa, Toshiyuki Sasagawa, Matomo Nishio, Junji Kobayashi.
Abstract
Clinical trials to date demonstrate that standard cancer treatments are currently the most efficient treatments for large numbers of cancer patients. Cancer treatments will increasingly require approaches that allow patients to live with cancer, by increasing their natural healing power and tumor immunity, as well as attenuating the progression of their cancers, instead of only attacking the cancer cells directly. Complementary and alternative medicine, including Kampo medicine, compensates for the drawbacks of western medicine by increasing patients' self-defense mechanisms. In Japan, clinicians who have studied both western medicine and Kampo treat cancer patients by fusing the two medical systems into a unitary one. The goal of the system is to assist the functional maintenance and recovery of the living body complex with the physical, mental, social, and spiritual balance, rather than addressing direct antitumor effects. In this review, we describe the usefulness of Kampo medicine, especially juzentaihoto, and outline the reports on evidence, in addition to the report on an attitudinal survey about the use of Kampo medicine in cancer treatment in Japan.Entities:
Year: 2013 PMID: 23997796 PMCID: PMC3723058 DOI: 10.1155/2013/570848
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Composition of juzentaihoto.
| Description | Juzentaihoto extract granules for ethical use | |
|---|---|---|
| Composition | 7.5 g of juzentaihoto extract granules contains 5.0 g of a dried extract of the following mixed crude drugs | |
| JP Astragalus Root | 3.0 g | |
| JP Cinnamon Bark | 3.0 g | |
| JP Rehmannia Root | 3.0 g | |
| JP Peony Root | 3.0 g | |
| JP Cnidium Rhizome | 3.0 g | |
| JP Atractylodes Lancea Rhizome | 3.0 g | |
| JP Japanese Angelica Root | 3.0 g | |
| JP Ginseng | 3.0 g | |
| JP Poria Sclerotium | 3.0 g | |
| JP Glycyrrhiza | 1.5 g | |
| Inactive ingredients | ||
| JP Magnesium Stearate | ||
| JP Lactose Hydrate | ||
Figure 13D-HPLC pattern of TJ-48 juzentaihoto.